Ultragenyx Pharmaceutical(RARE)及其关联方Bri,已与Esjay Pharma就Dojolvi相关专利诉讼达成和解。这一消息源自美国证券交易委员会(SEC)的官方文件披露。
Ultragenyx Pharmaceutical(RARE)及其关联方Bri,已与Esjay Pharma就Dojolvi相关专利诉讼达成和解。这一消息源自美国证券交易委员会(SEC)的官方文件披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.